BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7940725)

  • 41. Initial experiences in allogeneic bone marrow transplantation for leukaemias: report of National Institute of Haematology and Blood Transfusion (Hungary).
    Poros A; Petrányi J; Harsányi V; Mód A; Bernyäk J; Hollán Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):409-11. PubMed ID: 2480282
    [No Abstract]   [Full Text] [Related]  

  • 42. Bone marrow transplantation in childhood acute lymphoblastic leukemia with closely matched family donors in Hong Kong.
    Yuen PM; Chik KW; Li CK; Shing MM; Lai H
    Transplant Proc; 1996 Jun; 28(3):1748-9. PubMed ID: 8658866
    [No Abstract]   [Full Text] [Related]  

  • 43. Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantation.
    Giralt S; O'Brien S; Talpaz M; Van Besien K; Chan KW; Rondón G; Andersson B; Mehra R; Khouri I; Estey E
    Cytokines Mol Ther; 1995 Jun; 1(2):115-22. PubMed ID: 9384668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
    J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Allogeneic hematopoietic transplantation with stem cells extracted from peripheral blood].
    Kusminsky G; Foncuberta MC; Aversa L; Drelichman G; Freigeiro D; Burgos R; Irrazabal C; Gonzalez G; Dictar M; Niborski R; Kohan A; Sanchez Avalos JC
    Medicina (B Aires); 2000; 60(2):179-87. PubMed ID: 10962806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunophenotypic profile of peripheral blood eosinophils in acute graft-vs.-host disease.
    Rumi C; Rutella S; Bonini S; Bonini S; Lambiase A; Sica S; Puggioni P; Salutari P; Etuk B; Leone G
    Exp Hematol; 1998 Feb; 26(2):170-8. PubMed ID: 9472806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome of T cell-depleted transplantation after conditioning with an intensified regimen in patients aged 50 years or more is comparable with that in younger patients.
    Schattenberg A; Schaap N; Preijers F; van der Maazen R; de Witte T
    Bone Marrow Transplant; 2000 Jul; 26(1):17-22. PubMed ID: 10918401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclosporine-induced graft vs host disease in two patients receiving syngeneic bone marrow transplants.
    Dale BM; Atkinson K; Kotasek D; Biggs JC; Sage RE
    Transplant Proc; 1989 Oct; 21(5):3816-7. PubMed ID: 2815290
    [No Abstract]   [Full Text] [Related]  

  • 49. Haploidentical bone marrow transplantation in Mexico.
    Vázquez-Meraz JE; Arellano-Galindo J; Mendoza-García E; Jiménez-Hernández E; Martínez Avalos A; Velázquez Guadarrama N; Mejía Arangure JM
    Pediatr Blood Cancer; 2012 Nov; 59(5):950-2. PubMed ID: 22434694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Autologous bone marrow transplantation in infantile pathology].
    Muñoz Villa A
    An Esp Pediatr; 1989 Sep; 31 Suppl 39():114-7. PubMed ID: 2490309
    [No Abstract]   [Full Text] [Related]  

  • 51. [Transplantation of the bone marrow to patients with chronic granulocytic leukemia].
    Zduńczyk A
    Wiad Lek; 1988 Dec; 41(24):1652-7. PubMed ID: 3076730
    [No Abstract]   [Full Text] [Related]  

  • 52. CNS toxicity and high-dose busulphan in three patients undergoing bone marrow transplantation.
    Vasta S; Scimé R; Indovina A; Majolino I
    Haematologica; 1992; 77(2):189. PubMed ID: 1398309
    [No Abstract]   [Full Text] [Related]  

  • 53. Mother as HLA haploidentical marrow donor for children with advanced leukemia.
    Polchi P; Galimberti M; Lucarelli G; Durazzi SM; Angelucci E; Baronciani D; Donati M
    Bone Marrow Transplant; 1991; 7 Suppl 2():124. PubMed ID: 1878671
    [No Abstract]   [Full Text] [Related]  

  • 54. [The skin manifestations of the graft vs. host reaction].
    Biriukov AV; Baranov AE; Selidovkin GD; Evseeva LV; Getling ZM; Persina IS
    Vestn Dermatol Venerol; 1990; (5):16-9. PubMed ID: 2402935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transplants in ALL.
    Barrett AJ; Horowitz MM
    Bone Marrow Transplant; 1992; 10 Suppl 1():30-6. PubMed ID: 1521088
    [No Abstract]   [Full Text] [Related]  

  • 56. Current role and status of bone marrow transplantation.
    Brenner MK; Prentice HG
    Br J Hosp Med; 1989 Mar; 41(3):260-5. PubMed ID: 2653543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pediatric bone marrow transplantation.
    Chan KW
    Pediatr Dent; 1995; 17(4):291-3. PubMed ID: 7567633
    [No Abstract]   [Full Text] [Related]  

  • 58. Bowel permeability tests and acute graft-versus-host disease.
    Fegan CD; Whitaker JA
    Bone Marrow Transplant; 1995 May; 15(5):814-6. PubMed ID: 7670415
    [No Abstract]   [Full Text] [Related]  

  • 59. Transplantation with unrelated bone marrow in leukemic patients above 40 years of age.
    Ringdén O; Remberger M; Mattsson J; Aschan J; Hägglund H; Carlens S; Lönnqvist B; Sparrelid E; Ljungman P
    Transplant Proc; 1997 Nov; 29(7):3145-6. PubMed ID: 9365701
    [No Abstract]   [Full Text] [Related]  

  • 60. Neuropathy in chronic graft-versus-host disease caused by donor T cells.
    Haruki H; Koga M; Ogasawara J; Omoto M; Kawai M; Kanda T
    Muscle Nerve; 2012 Oct; 46(4):610-1. PubMed ID: 22987708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.